Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mazzotta

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Hepatology (Baltimore, Md.)|August 30, 2001
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infectionR A de Man, L M Wolters, F Nevens, et al.
HIV Medicine|June 13, 2002
Adherence to HIV treatment: results from a 1-year follow-up studyM Martini, S D'Elia, F Paoletti, et al.
HIV Medicine|July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex StudyC Torti, E Quiros-Roldan, L Scudeller, et al.
Journal of Medical Virology|April 1, 1997
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patientsR Iuliano, R Trovato, S Lico, et al.
Infection|July 1, 1996
Quantitation of HCV viraemia by branched DNA signal amplification in patients treated with alpha-interferon--a longitudinal studyR Iuliano, A M Pizzigallo, A Alecci, et al.
Immunology Letters|April 15, 1999
A role for mucosal immunity in resistance to HIV infectionM Clerici, A Salvi, D Trabattoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study GroupA d'Arminio Monforte, M Musicco, M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN studyS Nozza, L Galli, A Antinori, et al.
Infection|April 5, 2014
HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up studyS Taffon, D Genovese, M Blasi, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Hepatology (Baltimore, Md.)|August 30, 2001
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infectionR A de Man, L M Wolters, F Nevens, et al.
HIV Medicine|June 13, 2002
Adherence to HIV treatment: results from a 1-year follow-up studyM Martini, S D'Elia, F Paoletti, et al.
HIV Medicine|July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex StudyC Torti, E Quiros-Roldan, L Scudeller, et al.
Journal of Medical Virology|April 1, 1997
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patientsR Iuliano, R Trovato, S Lico, et al.
Infection|July 1, 1996
Quantitation of HCV viraemia by branched DNA signal amplification in patients treated with alpha-interferon--a longitudinal studyR Iuliano, A M Pizzigallo, A Alecci, et al.
Immunology Letters|April 15, 1999
A role for mucosal immunity in resistance to HIV infectionM Clerici, A Salvi, D Trabattoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study GroupA d'Arminio Monforte, M Musicco, M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN studyS Nozza, L Galli, A Antinori, et al.
Infection|April 5, 2014
HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up studyS Taffon, D Genovese, M Blasi, et al.
Pageof 8